Passive perinatal immunotherapy via transamniotic antibody delivery.
暂无分享,去创建一个
[1] D. Zurakowski,et al. Hematogenous Donor Cell Routing Pathway after Transamniotic Stem Cell Therapy. , 2020, Stem cells and development.
[2] D. Zurakowski,et al. Strategies in adjusting for multiple comparisons: A primer for pediatric surgeons. , 2020, Journal of pediatric surgery.
[3] D. Zurakowski,et al. Calculation of Confidence Intervals for Differences in Medians Between Groups and Comparison of Methods. , 2019, Anesthesia and analgesia.
[4] B. Firek,et al. Maternal IgA protects against the development of necrotizing enterocolitis in preterm infants , 2019, Nature Medicine.
[5] D. Zurakowski,et al. Donor mesenchymal stem cell linetics after transamniotic stem cell therapy (TRASCET) for experimental spina bifida. , 2018, Journal of pediatric surgery.
[6] G. Fouda,et al. The Impact of IgG Transplacental Transfer on Early Life Immunity , 2018, ImmunoHorizons.
[7] D. Zurakowski,et al. Fetal bone marrow homing of donor mesenchymal stem cells after transamniotic stem cell therapy (TRASCET). , 2017, Journal of pediatric surgery.
[8] A. Ohlsson,et al. Intravenous immunoglobulin for suspected or proven infection in neonates. , 2013, The Cochrane database of systematic reviews.
[9] G. Enders,et al. Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: a retrospective analysis , 2012, Journal of perinatal medicine.
[10] K. Furuya,et al. Fetal intraperitoneal injection of immunoglobulin diminishes alloimmune hemolysis , 2011, Journal of Perinatology.
[11] S. Akilesh,et al. FcRn: the neonatal Fc receptor comes of age , 2007, Nature Reviews Immunology.
[12] A. Kriplani,et al. Fetal Intravenous Immunoglobulin Therapy in Rhesus Hemolytic Disease , 2006, Gynecologic and Obstetric Investigation.
[13] N. Tsurushita,et al. An Engineered Human IgG1 Antibody with Longer Serum Half-Life , 2006, The Journal of Immunology.
[14] E. Jauniaux,et al. Materno-fetal immunoglobulin transfer and passive immunity during the first trimester of human pregnancy. , 1995, Human reproduction.
[15] M. Eibl,et al. The anti‐inflammatory effect of an oral immunoglobulin (IgA‐IgG) preparation and its possible relevance for the prevention of necrotizing enterocolitis , 1994, Acta paediatrica (Oslo, Norway : 1992). Supplement.
[16] M. Eibl,et al. Prevention of necrotizing enterocolitis in low-birth-weight infants by IgA-IgG feeding. , 1988, The New England journal of medicine.